Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders

D. Jamiolkowski, S. Kölker, EM. Glahn, I. Barić, J. Zeman, MR. Baumgartner, C. Mühlhausen, A. Garcia-Cazorla, F. Gleich, G. Haege, P. Burgard, . ,

. 2016 ; 39 (2) : 231-41. [pub] 20150827

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001039
E-zdroje Online Plný text

NLK ProQuest Central od 1999-02-01 do 2018-11-30
Medline Complete (EBSCOhost) od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1999-02-01 do 2018-11-30

BACKGROUND: Organic acidurias (OADs) and urea cycle disorders (UCDs) are inborn metabolic disorders with a risk for acute and chronic metabolic decompensation resulting in impairments of the central nervous system and other organ systems. So far, there is no systematic study of intellectual functioning, behavioural/emotional problems and health-related quality of life (HRQoL), and how these domains are connected. METHODS: Data of 152 patients with OADs (n = 100) and UCDs (n = 52) from the European Registry and Network of intoxication type Metabolic Diseases (E-IMD) using standardized instruments were compared with normative data. RESULTS: Behavioural/emotional problems are increased in OADs or UCDs patients by a factor of 2.5 (3.0), in female asymptomatic carriers of X-linked inherited UCD ornithine transcarbamylase deficiency (fasOTCD) by a factor of 1.5. All groups show similar patterns of behavioural/emotional problems, not different from epidemiological data. Mental disability (IQ ≤ 70) was found in 31% of OAD, 43% of UCD, but not in fasOTCD subjects. HRQoL was decreased in the physical domain, but in the normal range. Behavioural/emotional problems were significantly associated with intellectual functioning (OR = 6.24, 95%CI: 1.39-27.99), but HRQoL was independent from both variables. CONCLUSIONS: Patients with OADs and UCDs show increased frequencies of mental disability and behavioural/emotional problems. Profiles of behavioural/emotional problems were similar to epidemiological data. Intellectual disability and behavioural/emotional problems were strongly associated. Patients' HRQoL was in the normal range, possibly compensated by coping strategies of their families. Diagnostics and clinical care of OAD/UCD patients should be improved regarding behavioural/emotional, intellectual and quality of life aspects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001039
003      
CZ-PrNML
005      
20170119130753.0
007      
ta
008      
170103s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10545-015-9887-8 $2 doi
024    7_
$a 10.1007/s10545-015-9887-8 $2 doi
035    __
$a (PubMed)26310964
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Jamiolkowski, Dagmar $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany.
245    10
$a Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders / $c D. Jamiolkowski, S. Kölker, EM. Glahn, I. Barić, J. Zeman, MR. Baumgartner, C. Mühlhausen, A. Garcia-Cazorla, F. Gleich, G. Haege, P. Burgard, . ,
520    9_
$a BACKGROUND: Organic acidurias (OADs) and urea cycle disorders (UCDs) are inborn metabolic disorders with a risk for acute and chronic metabolic decompensation resulting in impairments of the central nervous system and other organ systems. So far, there is no systematic study of intellectual functioning, behavioural/emotional problems and health-related quality of life (HRQoL), and how these domains are connected. METHODS: Data of 152 patients with OADs (n = 100) and UCDs (n = 52) from the European Registry and Network of intoxication type Metabolic Diseases (E-IMD) using standardized instruments were compared with normative data. RESULTS: Behavioural/emotional problems are increased in OADs or UCDs patients by a factor of 2.5 (3.0), in female asymptomatic carriers of X-linked inherited UCD ornithine transcarbamylase deficiency (fasOTCD) by a factor of 1.5. All groups show similar patterns of behavioural/emotional problems, not different from epidemiological data. Mental disability (IQ ≤ 70) was found in 31% of OAD, 43% of UCD, but not in fasOTCD subjects. HRQoL was decreased in the physical domain, but in the normal range. Behavioural/emotional problems were significantly associated with intellectual functioning (OR = 6.24, 95%CI: 1.39-27.99), but HRQoL was independent from both variables. CONCLUSIONS: Patients with OADs and UCDs show increased frequencies of mental disability and behavioural/emotional problems. Profiles of behavioural/emotional problems were similar to epidemiological data. Intellectual disability and behavioural/emotional problems were strongly associated. Patients' HRQoL was in the normal range, possibly compensated by coping strategies of their families. Diagnostics and clinical care of OAD/UCD patients should be improved regarding behavioural/emotional, intellectual and quality of life aspects.
650    _2
$a předškolní dítě $7 D002675
650    _2
$a emoce $7 D004644
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mentální retardace $x etiologie $x metabolismus $7 D008607
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a duševní poruchy $x etiologie $x metabolismus $7 D001523
650    _2
$a metabolické nemoci $x komplikace $x metabolismus $7 D008659
650    _2
$a vrozené poruchy metabolismu $x komplikace $x metabolismus $7 D008661
650    _2
$a nemoc z nedostatku ornithinkarbamoyltransferázy $x komplikace $x metabolismus $7 D020163
650    _2
$a kvalita života $7 D011788
650    _2
$a vrozené poruchy cyklu močoviny $x komplikace $x metabolismus $7 D056806
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kölker, Stefan $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany.
700    1_
$a Glahn, Esther M $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany.
700    1_
$a Barić, Ivo $u Department of Pediatrcis, University Hospital Center Zagreb & University of Zagreb, School of Medicine, Zagreb, Croatia.
700    1_
$a Zeman, Jiri $u Department of Pediatrics, General Faculty Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Baumgartner, Matthias R $u Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland. Radiz - Rare Disease Initiative Zurich, Clinical Research Priority Program, University of Zurich, Zurich, Switzerland. Zurich Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
700    1_
$a Mühlhausen, Chris $u University Children's Hospital, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
700    1_
$a Garcia-Cazorla, Angels $u Hospital San Joan de Deu, Servicio de Neurologia and CIBERER, ISCIII, Barcelona, Spain.
700    1_
$a Gleich, Florian $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany.
700    1_
$a Haege, Gisela $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany.
700    1_
$a Burgard, Peter $u Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany. Peter.Burgard@med.uni-heidelberg.de.
700    1_
$a ,
773    0_
$w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 39, č. 2 (2016), s. 231-41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26310964 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170119130902 $b ABA008
999    __
$a ok $b bmc $g 1180179 $s 961606
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 39 $c 2 $d 231-41 $e 20150827 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...